Evidence map›Paper›PMID 25435891›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2014

Crotonis Fructus and Its Constituent, Croton Oil, Stimulate Lipolysis in OP9 Adipocytes.

Mi-Seong Kim, Ha-Rim Kim, Hong-Seob So, Young-Rae Lee, Hyoung-Chul Moon, Do-Gon Ryu, Sei-Hoon Yang, Guem-San Lee, Je-Ho Song, Kang-Beom Kwon

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Journal of breast cancer · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Mi-Seong KimCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Ha-Rim KimCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea ; BK21 Plus Program and Department of Smart Life-Care Convergence, Graduate School, Wonkwang University, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Hong-Seob SoCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea ; BK21 Plus Program and Department of Smart Life-Care Convergence, Graduate School, Wonkwang University, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Young-Rae LeeCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea ; Department of Oral Biochemistry, Wonkwang University School of Dentistry, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Hyoung-Chul MoonInstitute of Customized Physical Therapy, No. 217 Wallgye-ro, Gwangju Metropolitan City 506-303, Republic of Korea.
Do-Gon RyuDepartment of Korean Physiology, Wonkwang University School of Korean Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Sei-Hoon YangDepartment of Internal Medicine, Wonkwang University School of Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Guem-San LeeDepartment of Herbology, Wonkwang University School of Korean Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Je-Ho SongDepartment of Sports Industry & Welfare, Wonkwang University School of Natural Science, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Kang-Beom KwonCenter for Metabolic Function Regulation, Wonkwang University School of Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea ; BK21 Plus Program and Department of Smart Life-Care Convergence, Graduate School, Wonkwang University, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea ; Department of Korean Physiology, Wonkwang University School of Korean Medicine, No. 460 Iksan-Daero, Iksan, Jeonbuk 570-749, Republic of Korea.
Wonkwang University · KRAmerican Physical Therapy Association · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. Crotonis fructus (CF) is the mature fruit of Croton tiglium L. and has been used for the treatment of gastrointestinal disturbance in Asia. It is well known that the main component of CF is croton oil (CO). The present study is to investigate the effects of CF extracts (CFE) and CO on lipolysis in OP9 adipocytes. Methods. Glycerol release to the culture supernatants was used as a marker of adipocyte lipolysis. Results. Treatment with various concentrations of CFE and CO stimulates glycerol release in a dose-dependent manner. The increase in glycerol release by CFE is more potent than isoproterenol, which is a β-adrenergic agonist as a positive control in our system. The increased lipolysis by CFE and CO was accompanied by an increase of phosphorylated hormone sensitive lipase (pHSL) but not nonphosphorylated HSL protein and mRNA. Pretreatment with H89, which is a protein kinase A inhibitor, significantly abolished the CFE- and CO-induced glycerol release in OP9 adipocytes. These results suggest that CFE and CO may be a candidate for the development of a lipolysis-stimulating agent in adipocytes.

Identifiers

PMID25435891
PMCPMC4244682
OpenAlexW2167749629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.